Roger White provides an update on the TLC-2000, the newest product from Theralase

Big Al
August 14, 2015

Click download link to listen on this device: Download Show

We received a number of questions regarding the TLC-2000, the newest product of Theralase. Roger White elaborates on its current status.

    Aug 14, 2015 14:11 PM

    I work at a chiropractor clinic as a massage therapist. Our doctors/patients have been seeing excellent results with Theralase. The machines are a little pricey, but apparently they work. I have yet to have a treatment, but I will soon enough. I’ll keep you posted.


    Aug 17, 2015 17:36 AM

    Let me start by saying that this testimonial of mine is not solicited by any person representing the Theralase Corporation:

    As a full-time Chiropractor practicing since 1976, I have been Certified in Clinical Laser Acupuncture since 1986.

    I have had the pleasure of knowing Mr. Roger Dumoulin-White since 1999. At that time, I had the opportunity of beta-testing the original Theralase System, which has certainly evolved over these many years as being one of the best and technologically advanced clinical therapeutic lasers world-wide.

    Roger, his company product and representatives have over the years provided excellent professional clinical guidance, education and exceptional service even to the point of providing ‘loaner’ equipment during repairs.

    I highly recommend professionals seeking to purchase such equipment or renewing their outdated product(s) to consider Theralase as their first choice.

    Dr. Irving Pisarek

    Aug 17, 2015 17:22 PM

    I read US shareholder commentary re FDA and bureaucracy vs.cancer cure.
    Might it be better just to deal in Canada and Europe and forget the parasitic
    FDA? The Cure For All diseases and related DR. H CLARK books, one knows
    the cancer approaches chosen for application by TLT are exciting door openers
    in applied eradication of cancer tumors. That is the reason I am an investor.
    I will always take a chance on good vs evil (FDA)